Ideas to Action:

Independent research for global prosperity

CGD Policy Blogs


Challenges on the Road to Universal Access

At a satellite session on Sunday, a striking statistic was reported by the humanitarian organization Medecins Sans Frontieres: in one of its ARV treatment programs, 60 percent of project costs are going toward the treatment of 10 percent of patients. Why? After several years on standard ARV treatment regminens, many patients will inevitably develop resistance to the drugs and require newer ones.

Should We Expect More from Middle Income Countries?

The MCC is in final negotiations with El Salvador, one of two lower middle income countries (LMICs) deemed eligible in FY2006. Over the last year, we've heard bits and pieces of feedback from NGOs on the ground. Together with a review of the actual proposed compact (pdf), here's what I think is worth watching and discussing: